TMDX
TMDX
NASDAQ · Health Care

Transmedics Group Inc

$77.62
+3.79 (+5.13%)
Financial Highlights (FY 2026)
Revenue
516.18M
Net Income
162.22M
Gross Margin
59.9%
Profit Margin
31.4%
Rev Growth
+86.4%
D/E Ratio
1.08
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 59.9% 59.9% 41.3% 41.3%
Operating Margin 17.9% 16.1% 8.1% 9.9%
Profit Margin 31.4% 29.9% 6.6% 8.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 516.18M 276.89M 2.67B 2.60B
Gross Profit 309.30M 165.91M 1.10B 1.07B
Operating Income 92.55M 44.68M 215.76M 258.19M
Net Income 162.22M 78.32M 176.17M 221.55M
Gross Margin 59.9% 59.9% 41.3% 41.3%
Operating Margin 17.9% 16.1% 8.1% 9.9%
Profit Margin 31.4% 29.9% 6.6% 8.5%
Rev Growth +86.4% +86.4% -8.6% +8.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 707.92M 707.92M 1.93B 1.88B
Total Equity 653.61M 653.61M 2.11B 1.74B
D/E Ratio 1.08 1.08 0.92 1.08
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 92.74M 47.26M 309.48M 247.18M
Free Cash Flow 251.22M 206.55M